[] [Ordinary Shares Type and Class of Securities (Item 9.A.5 of Form 20-F) Preemptive Rights (Item 9.A.3 of Form 20-F) The holders of the Company’s ordinary shares do not have preemptive right. Limitations or Qualifications (Item 9.A.6 of Form 20-F) See “General,” “Voting Rights,” “Conversion of the ]
[] [Ordinary Shares Type and Class of Securities (Item 9.A.5 of Form 20-F) Preemptive Rights (Item 9.A.3 of Form 20-F) The holders of the Company’s ordinary shares do not have preemptive right. Limitations or Qualifications (Item 9.A.6 of Form 20-F) See “General,” “Voting Rights,” “Conversion of the ]
[] [THE COMPANIES LAW (2018 REVISION) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES SECOND AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF THE9 LIMITED (adopted by a Special Resolution passed on May 6, 2019) 1. The name of the Company is The9 Limited. 2. The Registered Office of the Company shall]
[] [THE COMPANIES LAW (2018 REVISION) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES SECOND AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF THE9 LIMITED (adopted by a Special Resolution passed on May 6, 2019) 1. The name of the Company is The9 Limited. 2. The Registered Office of the Company shall]
[CONTENTS] [SPECIMEN * NOT VALID UNLESS COUNTERSIGNED BY TRANSFER AGENT * INCORPORATED UNDER THE LAWS OF THE GOVERNMENT OF ANTIGUA Number Sinovac Shares BIOTECH LTD. This Certifies that Is the Owner of Fully paid and non-assessable shares of Common Stock of Sinovac Biotech Ltd. transferable on the bo]
[CONTENTS] [SPECIMEN * NOT VALID UNLESS COUNTERSIGNED BY TRANSFER AGENT * INCORPORATED UNDER THE LAWS OF THE GOVERNMENT OF ANTIGUA Number Sinovac Shares BIOTECH LTD. This Certifies that Is the Owner of Fully paid and non-assessable shares of Common Stock of Sinovac Biotech Ltd. transferable on the bo]
[None (Title of Class) None (Title of Class) Indicate the number of outstanding shares of each of the issuers classes of capital or common stock as of the close of the period covered by the annual report. As of December 31, 2019, 40,858,290 shares of common stock, par value US$0.10 per share, and on]
[None (Title of Class) None (Title of Class) Indicate the number of outstanding shares of each of the issuers classes of capital or common stock as of the close of the period covered by the annual report. As of December 31, 2019, 40,858,290 shares of common stock, par value US$0.10 per share, and on]
[NONE (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 35,524,950 ordinary shares, par value US$0.00375 per share. ☐ Yes ☒ No ☐ Yes ☒ No ☒ Yes ☐ No . ☒ Yes ☐ No ☐ Large] [P]
[NONE (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 35,524,950 ordinary shares, par value US$0.00375 per share. ☐ Yes ☒ No ☐ Yes ☒ No ☒ Yes ☐ No . ☒ Yes ☐ No ☐ Large] [P]
